Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Nature
|
August 19, 1993
Epidemic misuse
E H Williams, L Bunkley-Williams, J M Grizzle, et al.
Science (New York, N.Y.)
|
September 6, 2005
A strategy for probing the function of noncoding RNAs finds a repressor of NFAT
A T Willingham, A P Orth, S Batalov, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
August 2, 2013
Bivalve Biomarker Workshop: overview and discussion group summaries
A H Ringwood M J Hameedi R F Lee M Brouwer E C Peters G I Scott S N Luoma R T Digiulio
Oncogene
|
March 15, 2011
Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα
K B Grandinetti, T A Stevens, S Ha, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Nature
|
August 19, 1993
Epidemic misuse
E H Williams, L Bunkley-Williams, J M Grizzle, et al.
Science (New York, N.Y.)
|
September 6, 2005
A strategy for probing the function of noncoding RNAs finds a repressor of NFAT
A T Willingham, A P Orth, S Batalov, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
August 2, 2013
Bivalve Biomarker Workshop: overview and discussion group summaries
A H Ringwood M J Hameedi R F Lee M Brouwer E C Peters G I Scott S N Luoma R T Digiulio
Oncogene
|
March 15, 2011
Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα
K B Grandinetti, T A Stevens, S Ha, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
Page
of 3